ID: ALA2261616

Max Phase: Preclinical

Molecular Formula: C15H7ClN4O2

Molecular Weight: 310.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc(NC2=C(Cl)C(=O)c3ncncc3C2=O)cc1

Standard InChI:  InChI=1S/C15H7ClN4O2/c16-11-13(20-9-3-1-8(5-17)2-4-9)14(21)10-6-18-7-19-12(10)15(11)22/h1-4,6-7,20H

Standard InChI Key:  KACIYAGQRYIJOA-UHFFFAOYSA-N

Associated Targets(Human)

HCT-15 51914 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

XF498 12972 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-MEL-2 46422 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-OV-3 52876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 310.70Molecular Weight (Monoisotopic): 310.0258AlogP: 2.29#Rotatable Bonds: 2
Polar Surface Area: 95.74Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.89CX Basic pKa: CX LogP: 1.12CX LogD: 1.12
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.91Np Likeness Score: -0.98

References

1. Ryu C, Yi Y, Choi IH, Chae MJ, Han J, Jung O, Lee C.  (2004)  Synthesis and Cytotoxic Activity of 6-(Substituted-Phenyl)Amino-5,8-Quinazolinediones,  13  (5): [10.1007/s00044-004-0032-8]

Source